| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2011 | B cell depletion therapy exacerbates murine primary biliary cirrhosis. | Dhirapong, A; Lleo, A; Yang, GX; Tsuneyama, K; Dunn, R; Kehry, M; Packard, TA; Cambier, JC; Liu, FT ; Lindor, K; Coppel, RL; Ansari, AA; Gershwin, ME | Hepatology 53(2), 527-535 | | | |
| 2016 | Deletion of Galectin-3 Enhances Xenobiotic Induced Murine Primary Biliary Cholangitis by Facilitating Apoptosis of BECs and Release of Autoantigens. | Arsenijevic, A; Milovanovic, M; Milovanovic, J; Stojanovic, B; Zdravkovic, N; Leung, PS; Liu, FT ; Gershwin, ME; Lukic, ML | Scientific reports 6, 23348 | | | |
| 2016 | Galectin-3 regulates inflammasome activation in cholestatic liver injury. | Tian, J; Yang, G; Chen, HY; Hsu, DK; Tomilov, A; Olson, KA; Dehnad, A; Fish, SR; Cortopassi, G; Zhao, B; Liu, FT ; Gershwin, ME; Torok, NJ; Jiang, JX | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 30(12), 4202-4213 | | | |
| 2014 | Innate immunity drives xenobiotic-induced murine autoimmune cholangitis. | Chang, CH; Chen, YC; Yu, YH; Tao, MH; Leung, PS; Ansari, AA; Gershwin, ME; Chuang, YH | Clinical and experimental immunology 177(2), 373-380 | | | |
| 2009 | The immunological potential of galectin-1 and -3. | Dhirapong, A; Lleo, A; Leung, P; Gershwin, ME; Liu, FT | Autoimmunity reviews 8(5), 360-363 | | | |
| 2012 | Use of RNA Interference to Modulate Liver Adenoma Development in A Murine Model Transgenic for Hepatitis B Virus | Chen, CC; Chang, CM; Sun, CP ; Yu, CP; Wu, PY; Jeng, KS ; Hu, CP; Chen, PJ; Wu, JC; Shih, CH; Gershwin, ME; Tao, MH | Gene Therapy 19(1), 25-33 | | | |
